Oral Microbiota and Inflammatory Bowel Diseases: Detection of Emerging Fungal Pathogens and Herpesvirus
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(2), P. 480 - 480
Published: Feb. 15, 2025
Background/Objectives:
Ulcerative
colitis
(UC)
and
Crohn’s
disease
(CD)
are
the
usual
clinical
forms
of
inflammatory
bowel
(IBD).
Changes
in
oral
microbiota,
especially
presence
emerging
fungi
herpesviruses,
have
been
shown
to
worsen
aspects
IBD.
The
aim
this
study
was
screen
for
pathogens
yeast
microbiota
herpesvirus
IBD
patients.
Methods:
Oral
swabs
seven
UC
or
CD
patients
were
collected.
samples
plated
on
Sabouraud
Dextrose
Agar
subcultured
CHROMagar
Candida
Plus.
Polyphasic
taxonomy
applied
identified
using
molecular
tools,
such
as
MALDI-TOF
MS
ITS
partial
sequencing.
Multiplex
qPCR
used
identify
herpesvirus.
Results:
mean
age
38.67
±
14.06
years,
57.14%
female,
two
had
diabetes.
presented
with
Rhodotorula
mucilaginosa,
orthopsilosis
Kodamaea
jinghongensis,
while
Cutaneotrichosporon
dermatis,
glabrata,
lusitanea
tropicalis.
Two
individuals
at
least
one
In
first
individual,
a
co-detection
Herpes
Simplex
Virus
1
(HSV-1)
C.
lusitaniae
observed.
second
co-infections
Epstein–Barr
virus
(EBV),
Human
Herpesvirus
7
(HHV-7)
Conclusions:
We
rarely
described
yeasts
patients,
highlighting
need
they
may
contribute
opportunistic
infections.
Language: Английский
Oral Fusobacterium nucleatum exacerbates ulcerative colitis via the oral-gut axis: mechanisms and therapeutic implications
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2025,
Volume and Issue:
15
Published: April 7, 2025
Fusobacterium
nucleatum
(F.
nucleatum)
is
an
anaerobic
bacterium
known
for
its
association
with
periodontal
disease
and
oral
infections.
It
has
been
implicated
in
the
development
of
gastrointestinal
diseases
such
as
inflammatory
bowel
colorectal
cancer.
Ulcerative
colitis
(UC),
which
characterized
by
chronic
inflammation
colon,
a
condition
unknown
etiology
rising
incidence
rate,
significantly
affecting
quality
life
patients.
The
increased
intestinal
permeability
during
UC
may
facilitate
adherence
or
invasion
F.
into
damaged
barrier,
leading
to
exacerbated
inflammation.
This
article
introduces
concept
oral-gut
axis,
reviewing
existing
literature
analyze
role
pathogenesis
exploring
potential
pathogenic
mechanisms.
also
summarizes
latest
advances
treating
patients
who
have
looks
forward
prospective
therapeutic
strategies
translational
prospects
within
axis.
be
key
player
UC,
likely
due
invasiveness
periods
permeability.
paper
discusses
innovative
approaches
prevention
management
nucleatum,
paving
way
more
effective
treatment
UC.
review
offers
new
insights
complex
relationship
between
microbiome
diseases,
enhancing
our
understanding
their
dynamic
interactions.
There
paucity
on
approaches,
indicating
need
further
clinical
research.
Language: Английский
The effects of probiotic treatment with Bifidobacterium breve, Bif195 for small intestinal Crohn’s disease and the gut microbiome: results from a randomised, double-blind, placebo-controlled trial
Gut Pathogens,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: April 9, 2025
Language: Английский
Advancing gut microbiome insights: Graphene quantum dot nanobiosensors for microbial metabolite detection
Soheil Sadr,
No information about this author
Shakiba Nazemian,
No information about this author
Shiva Dianaty
No information about this author
et al.
Chemical Engineering Journal,
Journal Year:
2025,
Volume and Issue:
unknown, P. 162954 - 162954
Published: April 1, 2025
The Bidirectional Effects of Periodontal Disease and Oral Dysbiosis on Gut Inflammation in Inflammatory Bowel Disease
Journal of Crohn s and Colitis,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 24, 2024
Abstract
Background
and
Aims
Inflammatory
bowel
disease
(IBD)
flares
can
lead
to
excessive
morbidity
mortality.
This
study
aimed
determine
whether
oral
dysbiosis/periodontal
(PD)
is
common
in
IBD
associated
with
activity
IBD.
Methods
single-center,
prospective,
cross-sectional,
proof-of-concept,
observational
assessed
the
frequency
of
periodontal
inflammatory
interrogated
stool
microbiota
using
16S
rRNA
gene
amplicon
sequencing
active-IBD
(aIBD),
inactive-IBD
(iIBD),
healthy
controls
(HC).
Questionnaires
diet,
alcohol
usage,
hygiene
behavior,
activity.
A
subset
participants
underwent
comprehensive
dental
examinations
evaluate
PD.
Results
Periodontal
was
severer
aIBD
subjects
than
HC,
as
had
poorer
quality
diets
(lower
Mediterranean
diet
scores)
iIBD
HC.
Significant
differences
microbial
community
structure
were
observed
unstimulated
saliva,
stimulated
gingiva,
samples,
primarily
between
Saliva
from
higher
relative
abundances
putative
pathobionts
genera
Streptococcus,
Granulicatella,
Rothia,
Actinomyces
despite
similar
behaviors
groups.
Conclusions
Our
suggests
that
patients
have
disorders
‘pro-inflammatory’
their
cavity,
normal
behaviors.
data
are
consistent
potential
presence
an
oral-gut
axis
could
trigger
flare-ups
at-risk
patients.
Routine
health
assessments
all
should
be
encouraged
part
maintenance
a
strategy
decrease
risk
flares.
Language: Английский
Oral Microbiome Research in Biopsy Samples of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma and Its Challenges
Applied Sciences,
Journal Year:
2024,
Volume and Issue:
14(23), P. 11405 - 11405
Published: Dec. 7, 2024
This
study
aims
to
evaluate
the
potential
benefits
and
challenges
of
integrating
oral
microbiome
research
into
clinical
management
potentially
malignant
disorders
(OPMD)
squamous
cell
carcinoma
(OSCC).
The
has
gained
significant
attention
for
its
role
in
pathogenesis
progression
these
conditions,
with
emerging
evidence
suggesting
value
as
a
diagnostic
prognostic
tool.
By
critically
analyzing
current
methodological
considerations,
this
manuscript
examines
whether
analysis
biopsy
samples
can
aid
early
detection,
prognosis,
OPMD
OSCC.
complexity
dynamic
nature
require
multifaceted
approach
fully
understand
utility.
Based
on
review,
we
conclude
that
studying
context
holds
promise
but
also
faces
notable
challenges,
including
variability
need
standardization.
Ultimately,
addresses
question,
“Should
such
be
undertaken,
given
intricate
interactions
various
factors
inherent
obstacles
involved?”,
emphasizes
importance
further
optimize
applications
improve
patient
outcomes.
Language: Английский